Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours

Journal of Comparative Pathology

Volumn 150, Issue 1, 2014, Pages 27-34

  Guimaraes M J ^a   Carvalho, M I ^b   Pires, I ^b   Prada, J ^b   Gil, A Gonzalez ^c   Lopes, C ^a   Queiroga, F L ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Canine mammary tumours; COX 2; EGFR; Therapeutic target

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER SIZE; CELL NUCLEUS MEMBRANE; DISEASE ASSOCIATION; DOG; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MITOSIS INDEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCER;

CANINE MAMMARY TUMOURS; COX-2; EGFR; THERAPEUTIC TARGET;

ANIMALS; CARCINOMA; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84893735309     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2013.07.005     Document Type: Article

References (51)

1. Arun B., Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Seminars in Oncology 2004, 31:22-29.
2. Bhargava R., Gerald W.L., Li A.R., Pan Q., Lal P., et al. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Modern Pathology 2005, 18:1027-1033.
3. Brown J.R., DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. Journal of Clinical Oncology 2005, 23:2840-2855.
4. Buchanan F.G., Wang D., Bargiacchin F., DuBois R.N. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. Journal of Biological Chemistry 2003, 278:35451-35457.
5. Ceccarelli C., Piazzi G., Paterini P., Pantaleo M.A., Taffurelli M., et al. Concurrent EGFR and COX-2 expression in colorectal cancer: proliferation impact and tumour spreading. Annals of Oncology 2005, 16(Suppl. 4):74-79.
6. Chen W.C., McBride W.H., Chen S.M., Lee K.F., Hwang T.Z., et al. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and invitro studies. Head and Neck 2005, 27:503-512.
7. Chua D.T., Nicholls J.M., Sham J.S., Au G.K. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. International Journal of Radiation Oncology, Biology and Physics 2004, 59:11-20.
8. Costa C., Soares R., Reis-Filho J.S., Leitao D., Amendoeira I., et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. Journal of Clinical Pathology 2002, 55:429-434.
9. Dannenberg A.J., Lippman S.M., Mann J.R., Subbaramaiah K., DuBois R.N. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. Journal of Clinical Oncology 2005, 23:254-266.
10. Dias Pereira P., Lopes C.C., Matos A.J., Santos M., Gartner F., et al. COX-2 expression in canine normal and neoplastic mammary gland. Journal of Comparative Pathology 2009, 140:247-253.
11. Donnay I., Devleeschouwer N., Wouters-Ballman P., Leclercq G., Verstegen J. Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues. Research in Veterinary Science 1996, 60:251-254.
12. Donnay I., Rauis J., Wouters-Ballman P., Devleeschouwer N., Leclercq G., et al. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. Journal of Reproduction and Fertility 1993, 47:501-512.
13. Dore M., Lanthier I., Sirois J. Cyclooxygenase-2 expression in canine mammary tumors. Veterinary Pathology 2003, 40:207-212.
14. Gama A., Gartner F., Alves A., Schmitt F. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in canine mammary tissues. Research in Veterinary Science 2009, 87:432-437.
15. Goldschmidt M., Pena L., Rasotto R., Zappulli V. Classification and grading of canine mammary tumors. Veterinary Pathology 2011, 48:117-131.
16. Han C., Wu T. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. Journal of Biological Chemistry 2005, 280:24053-24063.
17. Heller D.A., Clifford C.A., Goldschmidt M.H., Holt D.E., Shofer F.S., et al. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma. Veterinary Pathology 2005, 42:776-780.
18. Higgins R.J., Dickinson P.J., LeCouteur R.A., Bollen A.W., Wang H., et al. Spontaneous canine gliomas: overexpression of EGFR, PDGFR-alpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. Journal of Neurooncology 2010, 98:49-55.
19. Hsia T.C., Tu C.Y., Chen Y.J., Wei Y.L., Yu M.C., et al. Lapatinib-mediated COX-2 expression via EGFR/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells. Molecular Pharmacology 2013, 83:857-869.
20. Huang T.L., Li C.F., Huang H.Y., Fang F.M. Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas. Chang Gung Medical Journal 2010, 33:619-627.
21. Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer 2005, 5:341-354.
22. Klijn J.G., Berns P.M., Schmitz P.I., Foekens J.A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrinology Reviews 1992, 13:3-17.
23. Lanza-Jacoby S., Burd R., Rosato F.E., McGuire K., Little J., et al. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer. Clinical Cancer Research 2006, 12:6161-6169.
24. Lavalle G.E., Bertagnolli A.C., Tavares W.L., Cassali G.D. COX-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival. Veterinary Pathology 2009, 46:1275-1280.
25. Lewis S., Locker A., Todd J.H., Bell J.A., Nicholson R., et al. Expression of epidermal growth factor receptor in breast carcinoma. Journal of Clinical Pathology 1990, 43:385-389.
26. Li F., Liu Y., Chen H., Liao D., Shen Y., et al. EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features. Journal of Experimental and Clinical Cancer Research 2011, 30:27.
27. Li Y., Wo J.M., Ray M.B., Jones W., Su R.R., et al. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma. World Journal of Gastroenterology 2006, 12:928-934.
28. Matsuura H., Sakaue M., Subbaramaiah K., Kamitani H., Eling T.E., et al. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. Journal of Biological Chemistry 1999, 274:29138-29148.
29. Millanta F., Citi S., Della Santa D., Porciani M., Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment 2006, 98:115-120.
30. Misdorp W., Else R.W., Hellmen E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, Vol. 7. Armed Forces Institute of Pathology and the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington DC.
31. Nerurkar V.R., Seshadri R., Mulherkar R., Ishwad C.S., Lalitha V.S., et al. Receptors for epidermal growth factor and estradiol in canine mammary tumors. International Journal of Cancer 1987, 40:230-232.
32. Pai R., Nakamura T., Moon W.S., Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB Journal 2003, 17:1640-1647.
33. Putti T.C., To K.F., Hsu H.C., Chan A.T., Lai G.M., et al. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 2002, 41:144-151.
34. Queiroga F.L., Alves A., Pires I., Lopes C. Expression of COX-1 and COX-2 in canine mammary tumours. Journal of Comparative Pathology 2007, 136:177-185.
35. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., et al. COX-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Research 2005, 25:4269-4275.
36. Queiroga F.L., Pires I., Lobo L., Lopes C.S. The role of COX-2 expression in the prognosis of dogs with malignant mammary tumours. Research in Veterinary Science 2010, 88:441-445.
37. Queiroga F.L., Pires I., Parente M., Gregorio H., Lopes C.S. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. Veterinary Journal 2011, 189:77-82.
38. Queiroga F.L., Raposo T., Carvalho M.I., Prada J., Pires I. Canine mammary tumours as a model to study human breast cancer: most recent findings. InVivo 2011, 25:455-465.
39. Rutteman G.R., Foekens J.A., Portengen H., Vos J.H., Blankenstein M.A., et al. Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs. Breast Cancer Research and Treatment 1994, 30:139-146.
40. Sabattini S., Mancini F.R., Marconato L., Bacci B., Rossi F., et al. EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival. Veterinary and Comparative Oncology 2012, [Epub ahead of print]. 10.1111/vco.12002.
41. Selvarajah G.T., Verheije M.H., Kik M., Slob A., Rottier P.J., et al. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis. Veterinary Journal 2012, 193:412-419.
42. Shien T., Tashiro T., Omatsu M., Masuda T., Furuta K., et al. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation. Journal of Clinical Pathology 2005, 58:1299-1304.
43. Shiomitsu K., Johnson C.L., Malarkey D.E., Pruitt A.F., Thrall D.E. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours. Veterinary and Comparative Oncology 2009, 7:106-114.
44. Simon D., Schoenrock D., Baumgartner W., Nolte I. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. Journal of Veterinary Internal Medicine 2006, 20:1184-1190.
45. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annual Review of Biochemistry 2000, 69:145-182.
46. Soo R., Putti T., Tao Q., Goh B.C., Lee K.H., et al. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Archives of Otolaryngology and Head and Neck Surgery 2005, 131:147-152.
47. Tamura M., Sebastian S., Gurates B., Yang S., Fang Z., et al. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. Journal of Clinical Endocrinology and Metabolism 2002, 87:3504-3507.
48. Tan K.B., Putti T.C. Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications. Journal of Clinical Pathology 2005, 58:535-538.
49. Tsutsui S., Ohno S., Murakami S., Hachitanda Y., Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Research and Treatment 2002, 71:67-75.
50. Van Dyke A.L., Cote M.L., Prysak G.M., Claeys G.B., Wenzlaff A.S., et al. COX-2/EGFR expression and survival among women with adenocarcinoma of the lung. Carcinogenesis 2008, 29:1781-1787.
51. Walker R.A., Dearing S.J. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Research and Treatment 1999, 53:167-176.